4921501E09Rik is a protein with an evolving understanding in scientific realms. A collection of chemical agents has been recognized to indirectly modulate its activity or expression. For instance, agents such as Forskolin and IBMX boost cAMP levels. An increase in cAMP can set off a cascade of cellular reactions, which has the potential to reshape the activity or expression of 4921501E09Rik. Anisomycin, by engaging the JNK pathway, and Oltipraz, through the activation of the Nrf2 pathway, can both redirect transcriptional landscapes, which in turn may reflect on the status of 4921501E09Rik.
Chemicals like PMA and EGF can activate their respective PKC and EGF receptor pathways. The mobilization of these pathways can weave a network of cellular events, some of which might converge on the modulation of 4921501E09Rik. Moreover, calcium ionophores like A23187 and Ionomycin can sway calcium-mediated cellular responses, thereby potentially steering the dynamics of 4921501E09Rik
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
As a phosphodiesterase inhibitor, it raises cAMP levels and can indirectly modulate cellular dynamics, potentially influencing 4921501E09Rik. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates protein kinase C (PKC), which in turn can modulate a plethora of cellular responses, including proteins like 4921501E09Rik. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Activates the JNK pathway, which has wide-reaching effects on cellular transcription, possibly relevant to 4921501E09Rik. | ||||||
Oltipraz | 64224-21-1 | sc-205777 sc-205777A | 500 mg 1 g | $286.00 $622.00 | ||
Invokes the Nrf2 pathway, thus regulating downstream transcriptional activity, potentially impacting 4921501E09Rik. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
As a cAMP analog, it prompts PKA activation, which can have downstream effects on proteins including 4921501E09Rik. | ||||||
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $96.00 $334.00 | 50 | |
Engages in various cellular pathways influencing transcriptional processes that can encompass 4921501E09Rik. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
Manipulates calcium-mediated cellular signaling, which can potentially modulate proteins like 4921501E09Rik. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
By altering calcium signaling, it can influence various downstream cellular processes potentially linked to 4921501E09Rik. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Histone deacetylase inhibitor that can modify gene expression patterns, potentially impacting 4921501E09Rik. | ||||||